At the beginning of 2020, RenaClinical, a company specialising in the supply of clinical trial medicinal products, purchased their first Riva Piccola tablet press from Riva Europe.
Eric Che, Technical Director with RenaClinical stated that “the Piccola is very flexible, robust, and operator friendly. All the products that have been used on the machine have run perfectly.”
Eric was also impressed with the level of service from Riva Europe. RenaClincal’s success in the market means that they hope to move to bigger premises in the future and a second Piccola would be first on their list of acquisitions.